Regeneron Pharmaceuticals, Inc. and Sanofi announced positive pivotal results from a second Phase 3 trial, PRIME, evaluating Dupixent® (dupilumab) in adults with uncontrolled prurigo...
Buckle up because transportation is evolving double quick time. It wasn't long ago that lane keep assist, approaching object alerts, automatic parallel parking and...
Wireless 20/20, LLC, a broadband network consulting group and developer of the industry-leading WiROI™ Broadband Networks Business Case Analysis Tools, announced the introduction of...
DocGo, a leading provider of last-mile mobile health services and integrated medical mobility solutions, announced it signed a multi-year contract to provide mobile at-home...
